Frazier Lifesciences Acquisition Corp. (FLAC) Shareholders Approve NewAmsterdam Pharma Deal
Frazier Lifesciences (NASDAQ:FLAC) announced this morning that its shareholders have approved its business combination with biotech firm NewAmsterdam Pharma Holding during a special meeting today.
The SPAC disclosed that holders of approximately 32% of FLAC Class A ordinary shares exercised their right to redeem their shares for cash, significantly lower than the average redemption rate for completed deals this year at 83.99%.
...READ MORE